411
Participants
Start Date
July 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Lapaquistat acetate and stable statin therapy
Lapaquistat acetate 50 mg, tablets, orally, once daily and stable statin therapy for up to 12 weeks.
Stable statin therapy
Lapaquistat acetate placebo-matching tablets, orally, once daily and stable statin therapy for up to 12 weeks.
Birmingham
Huntsville
Mobile
Tuscaloosa
Chandler
Gilbert
Glendale
Tucson
Artesia
Long Beach
Santa Ana
Santa Rosa
Tustin
Walnut Creek
Colorado Springs
Golden
Washington D.C.
Coral Gables
Fort Meyers
Hollywood
Jacksonville
Miami
New Port Richey
Pembroke Pines
Pensacola
Pinellas Park
Sarasota
St. Petersburg
West Palm Beach
Dunwoody
Idaho Falls
Aurora
Chicago
Evansville
Indianapolis
Iowa City
Overland Park
Wichita
Louisville
CantonAuburn
Scarborough
Baltimore
Haverhill
Ann Arbor
Brooklyn Center
Edina
Olive Branch
St Louis
Billings
Margate City
Wilwood
Asheville
Charlotte
Durham
Hickory
Raleigh
Salisbury
Statesville
Wilmington
Winston-Salem
Cincinnati
Kettering
Mentor
Zanesville
Oklahoma City
Portland
Altoona
Dowington
Sellerville
Warwick
Goose Creek
Greer
Mt. Pleasant
Simpsonville
Bristol
Austin
Corpus Christi
Dallas
Houston
Irving
San Antonio
Salt Lake City
Burke
Norfolk
Richmond
Wauwatosa
Lead Sponsor
Takeda
INDUSTRY